Last Updated on January 6, 2024 by The Health Master
The Union ministry of health and family welfare, Govt. of India, has constituted a seven-member panel to prepare a comprehensive ‘National Drugs Database’ of drug formulations manufactured and marketed in the country.
This will enhance regulatory oversight of medical products in the country to ensure their quality and bring uniformity to drug regulatory mechanisms across the country.
‘National Drugs Database’
According to a notification issued by the ministry on October 27, 2022, a committee has been set up to prepare a comprehensive “National Drugs Database’.
The committee comprises:
- Dr. HG Koshia, Commissioner, Food and Drugs Control Administration, Gujarat;
- AK Pradhan, Joint Drugs Controller, CDSCO;
- Dr. Pooja Gupta, Additional Professor, All India Institute of Medical Sciences, New Delhi;
- Dr. Jerian Jose, Scientist D, Indian Council of Medical Research, New Delhi;
- Dr. Gahane, Joint Commissioner, Food and Drug Administration, Maharashtra;
- BT Khanapure, State Drugs Controller, Karnataka;
- Navneet Marwaha, State Drugs Controller, Himachal Pradesh.
AK Pradhan will be the convener of the committee.
The committee will check the database already in place with different authorities, including state and union territory drug control offices, the Central Drugs Standard Control Organization (CDSCO), and different producers, distributors, and importers.
Furthermore, the committee will give recommendations and come up with a comprehensive “National Drugs Database” of drug formulations produced and marketed in the country.
The database will provide detailed information on the drug:
- Its dosage form,
- Strength,
- Details of the manufacturer, marketer, importer, etc.
These are crucial for not only empowering consumers but also for improving the monitoring mechanism for the quality of drugs in circulation, across the country and uniform administration of the regulatory system, etc.
The committee may co-opt any other expert as deemed necessary. In three months, the panel will deliver its recommendations to the ministry, along with the “National Drugs Database” of drug formulations.
The health ministry has increased efforts to make sure that medicines sold to people in India are secure, efficient, and meet established quality standards.
In July this year, the ministry released a draft of the Drugs, Medical Devices and Cosmetics Bill, 2022 with an aim of reviewing, replacing, and modernizing the obsolescent Drugs and Cosmetics Act, 1940 which it has been persistently reviewing and streamlining the rules to further accommodate the changes and to adopt the new technology.
The draft was prepared by an 8-member committee headed by the Drug Controller General of India, Dr. VG Somani.
DCGI to SDCs: Accept hard copy of application for registration of Medical Devices
USFDA issues Form 483 with 5 observations to Lupin
IPC introduces draft amendment to microbial contamination in IP 2022
USFDA issues Form 483 with one Observation to Laurus Labs
CDSCO Panel approves Tofacitinib Ointment 2% to Continue Clinical Trial Study
USFDA gives final approval for Paclitaxel injection
This State Pharmacy Council to appoint Pharmacy Inspectors
Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend
Two persons arrested in fake BP medicine racket
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
